stockMDG
Posted - 6 days ago
$PIRS so what happened with our pirs shares
Komo1
Posted - 1 week ago
$PIRS Palvella Director buying shares in the market https://ir.palvellatx.com/node/10421/html
NeilG
Posted - 1 week ago
$PIRS Yay!!!! We merged!!!! This is very exciting! 😴😴😴
Komo1
Posted - 1 week ago
$PIRS "on the Closing Date and immediately following the consummation of the Merger, the PIPE Investors purchased (either for cash or in exchange for the termination and cancellation of outstanding convertible promissory notes issued by Former Palvella), and the Company issued and sold to the PIPE Investors, an aggregate of 3,168,048 shares of the Company’s common stock at a price per share equal to $13.9965 (the “Purchase Price”), and/or in lieu of the Company’s common stock to certain purchasers who so choose due to beneficial ownership concerns, pre-funded warrants (the “Pre-Funded Warrants”) to purchase 2,466,456 shares of the Company’s common stock at a purchase price per Pre-Funded Warrant equal to the Purchase Price minus $0.001 (the “PIPE Financing”
DougieFreshPicks
Posted - 1 week ago
$PIRS look at it tonight let you know what I see on the chart 👍
DougieFreshPicks
Posted - 1 week ago
$NVDA $PIRS added to the list thanks 👍
IamLegend100
Posted - 1 week ago
@DougieFreshPicks $PIRS and $NVDA
PenkeTrading
Posted - 1 week ago
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Pieris Pharmaceuticals Inc. Is that bullish or bearish? $PIRS #Pieris #RsiOversold #NASDAQ
IamLegend100
Posted - 1 week ago
$PIRS Not selling for less then $15
IamLegend100
Posted - 1 week ago
$PIRS Why is this dropping on good news? I’m confused.?
Komo1
Posted - 2 weeks ago
$PIRS "The closing of the Merger is expected to occur on December 13, 2024, assuming the satisfaction or waiver of all conditions under the Merger Agreement. As previously disclosed, the Company will enter into a Contingent Value Rights Agreement with a rights agent, pursuant to which the Company’s pre-Merger capital stockholders of record on December 12, 2024 will receive one contingent value right for each outstanding share of the Company’s common stock held by such stockholder, or share of common stock underlying any preferred stocks held by such stockholder"
NVDAMillionaire
Posted - 2 weeks ago
$PIRS Pieris Pharmaceuticals (NASDAQ:PIRS): Navigating the Challenges and Embracing New Opportunities https://beyondspx.com/article/pieris-pharmaceuticals-nasdaqpirs-navigating-the-challenges-and-embracing-new-opportunities
NeilG
Posted - 3 weeks ago
$PIRS Good morning! Does anyone know when or if the Pavella merger is still going to happen?
BankingWithLiz
Posted - 1 month ago
$ABVE Super low float is making a huge move up ! Top watch for monday squeeze run! $EFSH popping $STAF due for s-1 cash raise $PIRS swinging
LabPsycho
Posted - 1 month ago
$PIRS @Biotechvalues if the below does not scream BioGrifters, I dont know what does.
insiderbuyingselling
Posted - 10/28/24
$PIRS new insider buying: 1 shares. http://insiderbuyingselling.com/?t=PIRS
emeraldstocktrader
Posted - 2 months ago
@HoHoHoHum $EIGRQ $PIRS
NeilG
Posted - 2 months ago
$PIRS Well, luckily I’ve only lost 7000.00 on this crap stock. It was great 5 years ago until I got into it and then I kept buying more and more averaging down to a reasonable break even price point 3.06 (before reverse split)
My shares are now worth under 500.00 so I’m all in. It’s not looking very promising unless something amazing happens with this merger. Good luck to all others that are in my same boat!!!
joe77w
Posted - 2 months ago
$PIRS It does seem CVR likely worthless, remote chance to get paid for asset sale, outlicensing 🤔☹️
BiotechValues
Posted - 3 months ago
$ONCT so $PIRS got a $10M valuation just for their Nasdaq listing, which is more than 2x current $ONCT market cap. If $ONCT monetizes the assets, distributes cash, and then monetizes the Nasdaq listing with a merger, could work out very well for shareholders at $4.5M market cap
WallStreetBuyDip
Posted - 3 months ago
How do you make your trade?
My summary for Small + Mid cap stocks. I ONLY buy when heaviness % is low.
The result speaks for itself. Got timestamps for the skeptics.
It's a simple strategy. Learn what "heaviness %" by Algos.
Will next trade $PIRS + $BCTX when H% is low.
WallStreetBuyDip
Posted - 3 months ago
How do you make your trade?
My summary for Small + Mid cap stocks. I ONLY buy when heaviness % is low.
The result speaks for itself. Got timestamps for the skeptics.
It's a simple strategy. Learn what "heaviness %" by Algos.
Will next trade $PIRS + $BCTX when H% is low.
WallStreetBuyDip
Posted - 3 months ago
How do you make your trade?
My summary for Small + Mid cap stocks. I ONLY buy when heaviness % is low.
The result speaks for itself. Got timestamps for the skeptics.
It's a simple strategy. Learn what "heaviness %" by Algos.
Will next trade $PIRS + $BCTX when H% is low.
WallStreetBuyDip
Posted - 3 months ago
How do you make your trade?
My summary for Small + Mid cap stocks. I ONLY buy when heaviness % is low.
The result speaks for itself. Got timestamps for the skeptics.
It's a simple strategy. Learn what "heaviness %" by Algos.
Will next trade $PIRS + $BCTX when H% is low.
NeilG
Posted - 08/30/24
$PIRS
NeilG
Posted - 08/30/24
$PIRS Is PIRS not trading today???
BiotechValues
Posted - 08/28/24
$GLTO I believe they are "copying" what $PIRS did ahead of their reverse merger (maybe even have the same bank/advisors). PIRS did a 1:80 reverse split and dropped their shares to 1.2M (see below). They then announced a merger transaction, with CVRs, and a $79M PIPE. The large R/S allows for the PIPE/merger to be made cleanly IMO (AKA let's reduce shares to lowest possible ahead of the merger/PIPE, since there will be a lot of new shares associated with those transactions). PIRS jumped from $7 to $18 on that news. I expect a similar outcome here. https://www.pieris.com/investors/news-events/press-releases/detail/706/pieris-pharmaceuticals-announces-1-for-80-reverse-stock https://www.pieris.com/investors/news-events/press-releases/detail/707/palvella-therapeutics-and-pieris-pharmaceuticals-announce